Schwameis, R.; Ganhoer-Schimboeck, J.; Hadjari, V.L.; Hefler, L.; Bergmeister, B.; Küssel, T.; Gittler, G.; Steindl-Schoenhuber, T.; Grimm, C.
TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers 2022, 14, 5991.
https://doi.org/10.3390/cancers14235991
AMA Style
Schwameis R, Ganhoer-Schimboeck J, Hadjari VL, Hefler L, Bergmeister B, Küssel T, Gittler G, Steindl-Schoenhuber T, Grimm C.
TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers. 2022; 14(23):5991.
https://doi.org/10.3390/cancers14235991
Chicago/Turabian Style
Schwameis, Richard, Julia Ganhoer-Schimboeck, Victoria Laudia Hadjari, Lukas Hefler, Birgit Bergmeister, Tatjana Küssel, Gunda Gittler, Theodora Steindl-Schoenhuber, and Christoph Grimm.
2022. "TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia" Cancers 14, no. 23: 5991.
https://doi.org/10.3390/cancers14235991
APA Style
Schwameis, R., Ganhoer-Schimboeck, J., Hadjari, V. L., Hefler, L., Bergmeister, B., Küssel, T., Gittler, G., Steindl-Schoenhuber, T., & Grimm, C.
(2022). TRICIN: A Phase II Trial on the Efficacy of Topical TRIchloroacetic Acid in Patients with Cervical Intraepithelial Neoplasia. Cancers, 14(23), 5991.
https://doi.org/10.3390/cancers14235991
